Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

176.46 -5.04 (-2.78%)
Official Closing Price Updated: 7:00 PM EST, Dec 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
64 65 Next >
AbbVie Provides Regulatory Update On Parkinson's Disease Drug Candidate
AbbVie Inc (NYSE: ABBV) provided a regulatory update on its New Drug Application (NDA) for  
Via Benzinga
Price Over Earnings Overview: AbbVie
Via Benzinga
4 Top Value Stock ETFs for Long-Term Wealth Building
It could be value's time to shine for the first time in years. 
Via The Motley Fool
This Is What Whales Are Betting On AbbVie
Via Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
Via Benzinga
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
It's still unclear whether CMS will include those drugs in its negotiation list. 
Via Investor's Business Daily
Is It Too Late to Buy AbbVie Stock?
AbbVie stock and earnings have increased over time. 
Via The Motley Fool
2 Top Dividend Kings to Buy for the Long Haul
These aren't just dividend plays, either. 
Via The Motley Fool
8 Analysts Have This to Say About AbbVie
Via Benzinga
2 Growth Stocks to Buy Before the Bull Market Arrives
Long-term investors shouldn't hesitate to add these stocks to their portfolios. 
Via The Motley Fool
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
Under Joe Biden's signature Inflation Reduction Act, drugmakers for twenty-seven drugs will be penalized for charging prices that rise faster than inflation for people with disabilities or the elderly... 
Via Benzinga
Oracle, AbbVie And This Gold Fund: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Oracle Corporation (NYSE: ORCL) as his pick. 
Via Benzinga
Dividend Income Update February 2023
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
5 Forever Dividend Stocks
These five dividend stocks make it a priority to return money to shareholders. 
Via The Motley Fool
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
Via Benzinga
3 No-Brainer Dividend Stocks to Buy in March
Going with these great dividend stocks is an easy choice. 
Via The Motley Fool
Reap Monthly Income With This Combination Of 3 Stocks
While the majority of stocks pay quarterly dividends, investors can still construct a portfolio that allows them to get paid monthly. 
Via Talk Markets
3 Surefire Stocks That Are Screaming Buys in March
High-growth industries are risky, but they also have tremendous potential. 
Via The Motley Fool
3 High-Yield Dividend Stocks to Buy Before the Next Bull Rally
Here's why you'll want to hurry up and buy these stocks before the next big market rally pushes them out of reach. 
Via The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Via Benzinga
7 Dividend Kings to Buy for an Uncertain Market Environment
With so much turbulence in the global economy, these dividend kings to buy may help you weather the extreme storm. 
Via InvestorPlace
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
Over the past week, the market had a nice uptick making it harder for defensive sectors like healthcare to get traction up only 0.51% and down almost 5% YTD. 
Via Talk Markets
2 High-Yield Dividend Stocks to Buy in March
Putting some shares of these stocks in your portfolio now could lead to heaps of passive income in your retirement years. 
Via The Motley Fool
Could This Humira Biosimilar Be a Winner for Amgen?
This Humira biosimilar just launched in the U.S. several weeks ago. 
Via The Motley Fool
Intel Slashed Its Dividend, But These 3 Yields Are Likely to Continue Rising
These are dividend stocks you won't have to worry about. 
Via The Motley Fool
These 2 Dividend Stocks Could Be a Great Addition to Your Income Portfolio
They'll generate cash now, and even more cash in the future. 
Via The Motley Fool
AbbVie Can Write Diversified Growth Story Without Humira, Rest Of The Business Has Strength, Analyst Says
Via Benzinga
3 Top Defensive Stocks to Own for a Focus on Quality
For those looking to invest in quality, look no further than these three top defensive stocks as ways to combat uncertainty in this market. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Via Benzinga
3 Value Stocks You'll Regret Not Buying on the Dip
These three undervalued healthcare stocks are solid picks for patient investors. 
Via The Motley Fool
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
64 65 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.